Catalyst Wire Dossier Catalyst Wire Dossier

Exparel (bupivacaine liposome injectable suspension)

bupivacaine liposome injectable suspension · Pacira BioSciences, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Exparel (bupivacaine liposome injectable suspension), covering 2017-11-20 to 2020-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty [Phase 3]

See pricing